NAGE
Niagen Bioscience, Inc.
2.80$
+4.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 56.3% | 56.3% | 75.2% | 79.0% | 87.7% | 64.4% | 85.9% | 88.3% | 79.7% | 91.2% | 86.5% | 83.3% | 84.0% | 84.6% | 86.1% | 90.1% | 93.9% | 91.0% | |
| 100.0% | 27.6% | 13.2% | 34.2% | 6.7% | 5.8% | 25.2% | 34.4% | 29.6% | 8.3% | 72.4% | 53.1% | 46.2% | 43.0% | 48.4% | 37.5% | 49.4% | 65.2% | 60.9% | |
| 100.0% | 27.6% | 13.2% | 34.2% | 6.7% | 5.8% | 25.2% | 34.4% | 29.6% | 8.3% | 72.4% | 53.1% | 46.2% | 43.0% | 48.4% | 37.5% | 49.4% | 65.2% | 60.9% | |
| – | 8.5% | 14.0% | 15.4% | 11.5% | 21.5% | 11.7% | 16.6% | 13.1% | 29.6% | 8.5% | 10.5% | 5.4% | 7.0% | 9.0% | 15.7% | 9.5% | 11.4% | 9.2% | |
| – | 17.4% | 25.9% | 21.9% | 46.3% | 57.6% | 24.5% | 32.4% | 43.6% | 40.1% | 9.2% | 19.5% | 28.7% | 30.5% | 23.5% | 27.2% | 26.4% | 13.5% | 19.2% | |
| – | 10.9% | 9.0% | 4.3% | 1.6% | 1.5% | 2.2% | 2.6% | 1.9% | 2.5% | 2.6% | 3.7% | 3.3% | 2.8% | 1.5% | 1.2% | 0.9% | 0.5% | 5.3% | |
| 69.0% | 57.2% | 70.6% | 24.1% | 59.1% | 55.8% | 37.0% | 65.3% | 71.9% | 49.5% | 14.2% | 35.6% | 49.2% | 57.2% | 45.1% | 47.0% | 48.2% | 32.5% | 28.1% | |
| 69.0% | 50.8% | 61.4% | 17.5% | 53.3% | 52.7% | 31.6% | 43.2% | 51.1% | 44.9% | 12.9% | 34.2% | 37.4% | 43.0% | 30.5% | 33.1% | 37.5% | 26.3% | 18.7% | |
| – | 1.9% | 0.8% | 1.2% | 1.2% | 0.9% | 1.5% | 3.2% | 9.3% | 1.3% | 0.3% | 0.4% | 2.1% | 1.6% | 0.9% | 1.3% | 1.3% | 1.5% | 0.9% | |
| 69.0% | 10.9% | 15.4% | 7.9% | 35.9% | 37.9% | 16.0% | 30.0% | 33.2% | 30.3% | 5.9% | 22.6% | 23.9% | 24.6% | 18.0% | 17.9% | 18.6% | 12.5% | 10.1% | |
| 31.0% | 42.8% | 29.4% | 75.9% | 40.9% | 44.2% | 63.0% | 34.7% | 28.1% | 50.5% | 85.8% | 64.4% | 50.8% | 42.8% | 54.9% | 53.0% | 51.8% | 67.5% | 71.9% | |
| -6,865.5% | -176.3% | -227.4% | -156.1% | -287.9% | -328.9% | -379.8% | -343.2% | -225.6% | -229.0% | -90.2% | -212.5% | -302.9% | -369.7% | -292.1% | -343.1% | -346.5% | -266.4% | -154.6% | |
| 921,752.8% | 231.1% | 269.6% | 247.2% | 363.1% | 354.2% | 370.9% | 308.1% | 191.4% | 188.8% | 71.1% | 130.2% | 141.8% | 159.2% | 116.2% | 129.0% | 136.4% | 116.8% | 80.3% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.